Boston Scientific Liabilities 2025

Boston Scientific Aktienanalyse

What does Boston Scientific do?

Boston Scientific Corp. is a global medical technology company specializing in the development and manufacturing of innovative solutions for medical challenges and needs. The company was founded in 1979 and has since been dedicated to meeting the individual needs of patients and medical professionals with innovative products. The history of Boston Scientific began in the 1960s when French engineer Jean-Marc Simon started developing pacemakers at the University of Minnesota. In 1969, Medtronic acquired Simon's pacemaker development, leading to the founding of Boston Scientific. From the beginning, the company focused on the production of cardiovascular implants, including pacemakers, implanted defibrillators, and stents. In the following years, the company achieved continued growth through acquisitions of competitors and advancements in research and development, particularly in the field of minimally invasive procedures. Today, Boston Scientific is a globally leading provider of innovative medical devices and solutions used in various areas of healthcare. Boston Scientific's business model is based on meeting the needs of patients, medical professionals, and healthcare policymakers in order to improve healthcare. The company works closely with doctors, hospitals, nursing facilities, and research institutions to continuously develop innovative solutions for various diseases and conditions. Boston Scientific has five business segments: Cardiovascular Systems, Interventional Oncology and Neuromodulation, Urology and Women's Health, Medical Oncology, and Endoscopy. The Cardiovascular Systems segment includes products and solutions for cardiovascular surgery, including pacemakers, implanted defibrillators, and catheters. The company is also involved in endovascular surgery, offering innovative stent and catheter systems for the treatment of aneurysms and arterial occlusive disease. The Interventional Oncology and Neuromodulation segment includes solutions for the minimally invasive treatment of cancer and chronic pain through catheter and implant systems. For example, Boston Scientific offers intensity-controlled radiofrequency ablation and neuromodulation procedures. The Urology and Women's Health segment includes products for the treatment and diagnosis of urogenital system disorders, including incontinence, urinary incontinence, and genital diseases. Boston Scientific offers innovative solutions for women, such as the treatment of urinary incontinence or the removal of uterine fibroids. The Medical Oncology segment includes products for the diagnosis and treatment of cancer, including in vitro diagnostics and novel treatments such as chemotherapy delivery technology. The Endoscopy segment includes endoscopic solutions, including the diagnosis and therapy of digestive tract, chest, and lung disorders. Boston Scientific's product portfolio is diverse and includes numerous innovative medical devices and systems designed to meet the needs of patients and medical professionals. Some of the notable products of the company include: - The Implantable Cardioverter-Defibrillator (ICD) is an innovative device that can treat heart rhythm disorders through the use of a remote control. - Drug-Eluting Stents are stents that deliver medication directly at the site of narrowing, promoting blood flow and helping to keep the artery open. - The Synergy is a top-of-the-line stent that has both a lower mortality rate and a higher success rate than conventional stents. - The Venus-EP Steerable Sheath is an advanced catheter that allows physicians unique navigation within the heart chambers. - The Precision is a catheter that sends impulses to the heart for the diagnosis and treatment of atrial fibrillation. - The Transcend is a pacemaker that combines traditional pacemaker function with a sensor that actively supports the patient during physical activity. - The Symphion is an innovative system for laparoscopic surgery that enables minimally invasive surgical procedures in women. In conclusion, Boston Scientific Corp. is a globally leading provider of innovative medical devices and solutions that run like a common thread through its various business segments. With a significant focus on research and development, the company offers a wide range of products to ensure that patients worldwide have access to innovative medical care. Through pioneering innovations, the development of new technologies, and collaboration with medical professionals, Boston Scientific will continue to defend its position as a leading provider of medical solutions worldwide. Boston Scientific ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Boston Scientific's Liabilities

Boston Scientific's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Boston Scientific's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Boston Scientific's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Boston Scientific's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Boston Scientific’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Boston Scientific stock

What is the level of liabilities of Boston Scientific this year?

Boston Scientific has a debt balance of 15.85 B USD this year.

What were the liabilities of Boston Scientific compared to the previous year?

The liabilities of Boston Scientific have increased by 6.43% increased compared to the previous year.

What are the consequences of high debt for investors of Boston Scientific?

High liabilities can pose a risk for investors of Boston Scientific, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Boston Scientific?

Low liabilities mean that Boston Scientific has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Boston Scientific affect the company?

An increase in liabilities of Boston Scientific can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Boston Scientific affect the company?

A decrease in the liabilities of Boston Scientific can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Boston Scientific?

Some factors that can influence the liabilities of Boston Scientific include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Boston Scientific so important for investors?

The liabilities of Boston Scientific are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Boston Scientific take to modify the liabilities?

To change its liabilities, Boston Scientific can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Boston Scientific pay?

Over the past 12 months, Boston Scientific paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Boston Scientific is expected to pay a dividend of 0 USD.

What is the dividend yield of Boston Scientific?

The current dividend yield of Boston Scientific is .

When does Boston Scientific pay dividends?

Boston Scientific pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Boston Scientific?

Boston Scientific paid dividends every year for the past 0 years.

What is the dividend of Boston Scientific?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Boston Scientific located?

Boston Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Boston Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Boston Scientific from 1/16/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/16/2025.

When did Boston Scientific pay the last dividend?

The last dividend was paid out on 1/16/2025.

What was the dividend of Boston Scientific in the year 2024?

In the year 2024, Boston Scientific distributed 0 USD as dividends.

In which currency does Boston Scientific pay out the dividend?

The dividends of Boston Scientific are distributed in USD.